Maintain Efficacy and Spare Toxicity: Traditional and New Radiation-Based Conditioning Regimens in Hematopoietic Stem Cell Transplantation.
Irene DogliottiMario LevisAurora MartinSara BartonciniFrancesco FelicettiChiara CavallinEnrico MaffiniMarco CerranoBenedetto BrunoUmberto RicardiLuisa GiacconePublished in: Cancers (2024)
Novelty in total body irradiation (TBI) as part of pre-transplant conditioning regimens lacked until recently, despite the developments in the field of allogeneic stem cell transplants. Long-term toxicities have been one of the major concerns associated with TBI in this setting, although the impact of TBI is not so easy to discriminate from that of chemotherapy, especially in the adult population. More recently, lower-intensity TBI and different approaches to irradiation (namely, total marrow irradiation, TMI, and total marrow and lymphoid irradiation, TMLI) were implemented to keep the benefits of irradiation and limit potential harm. TMI/TMLI is an alternative to TBI that delivers more selective irradiation, with healthy tissues being better spared and the control of the radiation dose delivery. In this review, we discussed the potential radiation-associated long-term toxicities and their management, summarized the evidence regarding the current indications of traditional TBI, and focused on the technological advances in radiotherapy that have resulted in the development of TMLI. Finally, considering the most recent published trials, we postulate how the role of radiotherapy in the setting of allografting might change in the future.
Keyphrases
- traumatic brain injury
- radiation induced
- severe traumatic brain injury
- mild traumatic brain injury
- stem cells
- radiation therapy
- locally advanced
- gene expression
- stem cell transplantation
- systematic review
- squamous cell carcinoma
- bone marrow
- acute myeloid leukemia
- randomized controlled trial
- high dose
- oxide nanoparticles